BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22613727)

  • 1. Calpain induces N-terminal truncation of β-catenin in normal murine liver development: diagnostic implications in hepatoblastomas.
    Lade A; Ranganathan S; Luo J; Monga SP
    J Biol Chem; 2012 Jun; 287(27):22789-98. PubMed ID: 22613727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cleavage of E-cadherin and β-catenin by calpain affects Wnt signaling and spheroid formation in suspension cultures of human pluripotent stem cells.
    Konze SA; van Diepen L; Schröder A; Olmer R; Möller H; Pich A; Weißmann R; Kuss AW; Zweigerdt R; Buettner FF
    Mol Cell Proteomics; 2014 Apr; 13(4):990-1007. PubMed ID: 24482122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization of beta-catenin affects mouse embryonic liver growth and hepatoblast fate.
    Decaens T; Godard C; de Reyniès A; Rickman DS; Tronche F; Couty JP; Perret C; Colnot S
    Hepatology; 2008 Jan; 47(1):247-58. PubMed ID: 18038450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas.
    Wei Y; Fabre M; Branchereau S; Gauthier F; Perilongo G; Buendia MA
    Oncogene; 2000 Jan; 19(4):498-504. PubMed ID: 10698519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
    Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
    Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor 10 is critical for liver growth during embryogenesis and controls hepatoblast survival via beta-catenin activation.
    Berg T; Rountree CB; Lee L; Estrada J; Sala FG; Choe A; Veltmaat JM; De Langhe S; Lee R; Tsukamoto H; Crooks GM; Bellusci S; Wang KS
    Hepatology; 2007 Oct; 46(4):1187-97. PubMed ID: 17668871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-catenin mutations and protein accumulation in all hepatoblastomas examined from B6C3F1 mice treated with anthraquinone or oxazepam.
    Anna CH; Sills RC; Foley JF; Stockton PS; Ton TV; Devereux TR
    Cancer Res; 2000 Jun; 60(11):2864-8. PubMed ID: 10850429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-catenin antisense studies in embryonic liver cultures: role in proliferation, apoptosis, and lineage specification.
    Monga SP; Monga HK; Tan X; Mulé K; Pediaditakis P; Michalopoulos GK
    Gastroenterology; 2003 Jan; 124(1):202-16. PubMed ID: 12512043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver.
    Tan X; Apte U; Micsenyi A; Kotsagrelos E; Luo JH; Ranganathan S; Monga DK; Bell A; Michalopoulos GK; Monga SP
    Gastroenterology; 2005 Jul; 129(1):285-302. PubMed ID: 16012954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deleting the β-catenin degradation domain in mouse hepatocytes drives hepatocellular carcinoma or hepatoblastoma-like tumor growth.
    Loesch R; Caruso S; Paradis V; Godard C; Gougelet A; Renault G; Picard S; Tanaka I; Renoux-Martin Y; Perret C; Taketo MM; Zucman-Rossi J; Colnot S
    J Hepatol; 2022 Aug; 77(2):424-435. PubMed ID: 35257829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of potential beta-catenin targets, cyclin D1, c-Jun, c-Myc, E-cadherin, and EGFR in chemically induced hepatocellular neoplasms from B6C3F1 mice.
    Anna CH; Iida M; Sills RC; Devereux TR
    Toxicol Appl Pharmacol; 2003 Jul; 190(2):135-45. PubMed ID: 12878043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calpain-mediated N-cadherin proteolytic processing in brain injury.
    Jang YN; Jung YS; Lee SH; Moon CH; Kim CH; Baik EJ
    J Neurosci; 2009 May; 29(18):5974-84. PubMed ID: 19420263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta-Catenin and met deregulation in childhood Hepatoblastomas.
    Ranganathan S; Tan X; Monga SP
    Pediatr Dev Pathol; 2005; 8(4):435-47. PubMed ID: 16211454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calpain-mediated truncation of GSK-3 in post-mortem brain samples.
    Goñi-Oliver P; Avila J; Hernández F
    J Neurosci Res; 2009 Apr; 87(5):1156-61. PubMed ID: 19006085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors.
    López-Terrada D; Gunaratne PH; Adesina AM; Pulliam J; Hoang DM; Nguyen Y; Mistretta TA; Margolin J; Finegold MJ
    Hum Pathol; 2009 Jun; 40(6):783-94. PubMed ID: 19200579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver.
    Kim Y; Sills RC; Houle CD
    Toxicol Pathol; 2005; 33(1):175-80. PubMed ID: 15805069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-catenin regulates vitamin C biosynthesis and cell survival in murine liver.
    Nejak-Bowen KN; Zeng G; Tan X; Cieply B; Monga SP
    J Biol Chem; 2009 Oct; 284(41):28115-28127. PubMed ID: 19690176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas.
    Yamada S; Ohira M; Horie H; Ando K; Takayasu H; Suzuki Y; Sugano S; Hirata T; Goto T; Matsunaga T; Hiyama E; Hayashi Y; Ando H; Suita S; Kaneko M; Sasaki F; Hashizume K; Ohnuma N; Nakagawara A
    Oncogene; 2004 Aug; 23(35):5901-11. PubMed ID: 15221005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CITED1 expression in liver development and hepatoblastoma.
    Murphy AJ; de Caestecker C; Pierce J; Boyle SC; Ayers GD; Zhao Z; Libes JM; Correa H; Walter T; Huppert SS; Perantoni AO; de Caestecker MP; Lovvorn HN
    Neoplasia; 2012 Dec; 14(12):1153-63. PubMed ID: 23308048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice.
    Tao J; Calvisi DF; Ranganathan S; Cigliano A; Zhou L; Singh S; Jiang L; Fan B; Terracciano L; Armeanu-Ebinger S; Ribback S; Dombrowski F; Evert M; Chen X; Monga SPS
    Gastroenterology; 2014 Sep; 147(3):690-701. PubMed ID: 24837480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.